KSB SE & Co. KGaA
KSB SE & Co. KGaA (KSB.DE) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for KSB SE & Co. KGaA (KSB.DE), featuring income statements, balance sheets, and cash flow data.
KSB SE & Co. KGaA (KSB.DE) Income Statement & Financial Overview
View the income breakdown for KSB SE & Co. KGaA KSB.DE across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.95B | $7.26B | $6.17B | $6.46B |
| Cost of Revenue | $3.23B | $4.97B | $3.33B | $4.53B |
| Gross Profit | $2.72B | $2.30B | $2.84B | $1.93B |
| Gross Profit Ratio | $0.46 | $0.32 | $0.46 | $0.30 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $1.33B | $0.00 | $1.16B |
| Operating Expenses | $2.18B | $1.33B | $2.10B | $1.16B |
| Total Costs & Expenses | $5.42B | $6.42B | $5.43B | $5.69B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $8.00M | $4.00M | $6.00M | $8.00M |
| Depreciation & Amortization | $139.00M | $144.24M | $137.00M | $133.00M |
| EBITDA | $837.00M | $1.09B | $974.00M | $1.04B |
| EBITDA Ratio | $0.14 | $0.15 | $0.16 | $0.16 |
| Operating Income | $538.00M | $840.00M | $739.00M | $773.00M |
| Operating Income Ratio | $0.09 | $0.12 | $0.12 | $0.12 |
| Other Income/Expenses (Net) | $152.00M | $139.50M | $92.00M | $126.00M |
| Income Before Tax | $690.00M | $979.50M | $831.00M | $899.00M |
| Income Before Tax Ratio | $0.12 | $0.13 | $0.13 | $0.14 |
| Income Tax Expense | $174.00M | $249.00M | $214.00M | $218.00M |
| Net Income | $516.00M | $731.00M | $617.00M | $681.00M |
| Net Income Ratio | $0.09 | $0.10 | $0.10 | $0.11 |
| EPS | $2.97 | $4.21 | $3.55 | $3.91 |
| Diluted EPS | $2.97 | $4.21 | $3.55 | $3.91 |
| Weighted Avg Shares Outstanding | $173.74M | $174.04M | $173.80M | $174.17M |
| Weighted Avg Shares Outstanding (Diluted) | $173.74M | $174.04M | $173.80M | $174.17M |
Over the past four quarters, KSB SE & Co. KGaA demonstrated steady revenue growth, increasing from $6.46B in Q2 2024 to $5.95B in Q1 2025. Operating income reached $538.00M in Q1 2025, maintaining a consistent 9% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $837.00M, reflecting operational efficiency. Net income dropped to $516.00M, with EPS at $2.97. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan